Abstract
Persistent Müllerian duct syndrome (PMDS) is a rare difference of sex development, characterized by the presence of Müllerian duct derivatives in 46,XY individuals with male-typical development. PMDS typically presents during childhood with features of cryptorchidism, inguinal hernia or transverse testicular ectopia. Untreated PMDS is associated with risks of infertility and malignancy. Infertility is common, arising from cryptorchidism, anatomical malformations (such as epididymal aplasia) or extrinsic compression of the ejaculatory duct by Müllerian structures. At the time of diagnosis, just one in five men with PMDS are reported to have conceived naturally. Preservation of fertility potential requires prompt diagnosis and management via a holistic patient-centred approach that addresses the underlying cause. With cryptorchidism, which is a common manifestation of PMDS, early orchidopexy is the key initial intervention. The input of fertility specialists and assisted reproductive techniques can further support successful conception. Beyond its effects on fertility, PMDS carries a risk of malignant transformation in the testes and Müllerian structures, warranting complex management with inclusion of a multi-disciplinary team and consideration of orchidopexy, orchidectomy, excision of Müllerian remnants and onward surveillance. Thus, although rare, PMDS is an important cause of male factor infertility that might be encountered by urologists. Preservation of fertility potential requires a high index of clinical suspicion and timely intervention. Raising awareness of PMDS among clinicians is crucial to improve its detection, advance its clinical management and provide a basis for future research.
Key points
-
Persistent Müllerian duct syndrome (PMDS) most commonly presents in childhood, with non-specific features of cryptorchidism, inguinal hernia or transverse testicular ectopia.
-
PMDS is a rare but important cause of male factor infertility that requires a high index of suspicion for early detection and timely management.
-
In addition to its effects on male fertility, PMDS also risks malignant transformation of the testes and/or Müllerian duct derivatives.
-
Consensus is lacking regarding the optimal approach to the investigation and management of PMDS.
-
The current evidence base is limited by the low numbers of cases reported in the literature and lack of follow-up studies; in the future, global clinical databases could promote and support research.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout


Similar content being viewed by others
References
Renu, D., Rao, B. G., Ranganath, K. & Namitha Persistent mullerian duct syndrome. Indian J. Radiol. Imaging 20, 72–74 (2010).
Picard, J. Y., Cate, R. L., Racine, C. & Josso, N. The persistent müllerian duct syndrome: an update based upon a personal experience of 157 cases. Sex. Dev. 11, 109–125 (2017).
Gutte, A. A., Pendharkar, P. S. & Sorte, S. Z. Transverse testicular ectopia associated with persistent Mullerian duct syndrome - the role of imaging. Br. J. Radiol. 81, e176–e178 (2008).
Jandou, I. et al. Hypofertility in a persistence of mullerian duct syndrome: case report. Int. J. Surg. Case Rep. 77, 778–781 (2020).
Elias-Assad, G., Elias, M., Kanety, H., Pressman, A. & Tenenbaum-Rakover, Y. Persistent Müllerian duct syndrome caused by a novel mutation of an anti-müilerian hormone receptor gene: case presentation and literature review. Pediatr. Endocrinol. Rev. 13, 731–740 (2016).
Josso, N., Picard, J. Y., Imbeaud, S., di Clemente, N. & Rey, R. Clinical aspects and molecular genetics of the persistent Müllerian duct syndrome. Clin. Endocrinol. 47, 137–144 (1997).
Wilson, D. & Bordoni, B. Embryology, Mullerian Ducts (Paramesonephric Ducts) (StatPearls, 2023).
Kobayashi, A. & Behringer, R. R. Developmental genetics of the female reproductive tract in mammals. Nat. Rev. Genet. 4, 969–980 (2003).
Zhao, F. & Yao, H. H. A tale of two tracts: history, current advances, and future directions of research on sexual differentiation of reproductive tracts. Biol. Reprod. 101, 602–616 (2019).
Josso, N. Professor Alfred Jost: the builder of modern sex differentiation. Sex. Dev. 2, 55–63 (2008).
Jost, A. Problems of fetal endocrinology: the gonadal and hypophyseal hormones. Recent Prog. Horm. Res. 8, 379–418 (1953).
Jost, A. Problems of fetal endocrinology: the adrenal glands. Recent Prog. Horm. Res. 22, 541–574 (1966).
Josso, N. In vitro synthesis of Müllerian-inhibiting hormone by seminiferous tubules isolated from the calf fetal testis. Endocrinology 93, 829–834 (1973).
Cate, R. L. et al. Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 45, 685–698 (1986).
Rey, R. Anti-Müllerian hormone in disorders of sex determination and differentiation. Arq. Bras. Endocrinol. Metab. 49, 26–36 (2005).
Kucinskas, L. & Just, W. Human male sex determination and sexual differentiation: pathways, molecular interactions and genetic disorders. Medicina 41, 633–640 (2005).
Gagliardi, F. et al. The risk of malignant degeneration of Müllerian derivatives in PMDS: a review of the literature. J. Clin. Med. 12, 3115 (2023).
Okashita, N. & Tachibana, M. Transcriptional regulation of the Y-linked mammalian testis-determining gene SRY. Sex. Dev. 15, 351–359 (2021).
Gupta, C. & Singh, M. Stimulation of epidermal growth factor gene expression during the fetal mouse reproductive tract differentiation: role of androgen and its receptor. Endocrinology 137, 705–711 (1996).
Gupta, C., Siegel, S. & Ellis, D. The role of EGF in testosterone-induced reproductive tract differentiation. Dev. Biol. 146, 106–116 (1991).
Okazawa, M. et al. Region-specific regulation of cell proliferation by FGF receptor signaling during the Wolffian duct development. Dev. Biol. 400, 139–147 (2015).
Nguyen, A. P., Chandorkar, A. & Gupta, C. The role of growth hormone in fetal mouse reproductive tract differentiation. Endocrinology 137, 3659–3666 (1996).
Baker, J. et al. Effects of an Igf1 gene null mutation on mouse reproduction. Mol. Endocrinol. 10, 903–918 (1996).
Heldin, C. H. & Moustakas, A. Signaling receptors for TGF-β family members. Cold Spring Harb. Perspect. Biol. 8, a022061 (2016).
Klattig, J., Sierig, R., Kruspe, D., Besenbeck, B. & Englert, C. Wilms’ tumor protein Wt1 is an activator of the anti-Müllerian hormone receptor gene Amhr2. Mol. Cell Biol. 27, 4355–4364 (2007).
Roberts, L. M., Visser, J. A. & Ingraham, H. A. Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development. Development 129, 1487–1496 (2002).
Clevers, H. & Nusse, R. Wnt/β-catenin signaling and disease. Cell 149, 1192–1205 (2012).
Parr, B. A. & McMahon, A. P. Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature 395, 707–710 (1998).
Nishi, M. Y. et al. Analysis of anti-Müllerian hormone (AMH) and its receptor (AMHR2) genes in patients with persistent Müllerian duct syndrome. Arq. Bras. Endocrinol. Metab. 56, 473–478 (2012).
Mullen, R. D., Ontiveros, A. E., Moses, M. M. & Behringer, R. R. AMH and AMHR2 mutations: a spectrum of reproductive phenotypes across vertebrate species. Dev. Biol. 455, 1–9 (2019).
Menabò, S. et al. Three novel AMH gene mutations in a patient with persistent Mullerian duct syndrome and normal AMH serum dosage. Horm. Res. 70, 124–128 (2008).
van der Zwan, Y. G. et al. A novel AMH missense mutation in a patient with persistent Müllerian duct syndrome. Sex. Dev. 6, 279–283 (2012).
Wongprasert, H., Somanunt, S., De Filippo, R., Picard, J. Y. & Pitukcheewanont, P. A novel mutation of anti-Mullerian hormone gene in persistent mullerian duct syndrome presented with bilateral cryptorchidism: a case report. J. Pediatr. Urol. 9, e147–e149 (2013).
Morikawa, S., Moriya, K., Ishizu, K. & Tajima, T. Two heterozygous mutations of the AMH gene in a Japanese patient with persistent Müllerian duct syndrome. J. Pediatr. Endocrinol. Metab. 27, 1223–1226 (2014).
Altincik, A., Karaca, F. & Onay, H. Persistent Müllerian duct syndrome: a novel mutation in the anti-Müllerian hormone gene. Hormones 16, 205–208 (2017).
Josso, N., Belville, C., di Clemente, N. & Picard, J. Y. AMH and AMH receptor defects in persistent Müllerian duct syndrome. Hum. Reprod. Update 11, 351–356 (2005).
Cima, L. N. et al. Persistent Müllerian duct syndrome with supernumerary testicles due to a novel homozygous variant in the AMHR2 gene and literature review. Diagnostics 14, 2621 (2024).
Tosca, L. et al. Persistent Müllerian duct syndrome due to anti-Müllerian hormone receptor 2 microdeletions: a diagnostic challenge. Hum. Reprod. 35, 999–1003 (2020).
Fotiadou, A. et al. A novel mutation in the AMHR2 gene, resulting in persistent Müllerian duct syndrome presenting with bilateral cryptorchidism and obstructed inguinal hernia. J. Pediatr. Endocrinol. Metab. 36, 890–894 (2023).
MacLaughlin, D. T. & Donahoe, P. K. Sex determination and differentiation. N. Engl. J. Med. 350, 367–378 (2004).
Picard, J.-Y. et al. Persistent Müllerian duct syndrome associated with genetic defects in the regulatory subunit of myosin phosphatase. Hum. Reprod. 37, 2952–2959 (2022).
Xia, D., Stull, J. T. & Kamm, K. E. Myosin phosphatase targeting subunit 1 affects cell migration by regulating myosin phosphorylation and actin assembly. Exp. Cell Res. 304, 506–517 (2005).
Matsumura, F. & Hartshorne, D. J. Myosin phosphatase target subunit: many roles in cell function. Biochem. Biophys. Res. Commun. 369, 149–156 (2008).
Grassie, M. E., Moffat, L. D., Walsh, M. P. & MacDonald, J. A. The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1δ. Arch. Biochem. Biophys. 510, 147–159 (2011).
Hutson, J. M., Grover, S. R., O’Connell, M. & Pennell, S. D. Malformation syndromes associated with disorders of sex development. Nat. Rev. Endocrinol. 10, 476–487 (2014).
Weiss, E. B., Kiefer, J. H., Rowlatt, U. F. & Rosenthal, I. M. Persistent Müllerian duct syndrome in male identical twins. Pediatrics 61, 797–800 (1978).
Chen, H., Lin, P., Yuan, X. & Chen, R. Two novel AMHR2 gene variants in monozygotic twins with persistent Müllerian duct syndrome: a case report and functional study. Mol. Genet. Genom. Med. 10, e1999 (2022).
Nalbantoğlu, Ö et al. A novel mutation of AMH in three siblings with persistent Mullerian duct syndrome. J. Pediatr. Endocrinol. Metab. 28, 1379–1382 (2015).
Unal, E. et al. A novel mutation of AMHR2 in two siblings with persistent Müllerian duct syndrome. J. Clin. Res. Pediatr. Endocrinol. 10, 387–-390 (2018).
Abduljabbar, M., Taheini, K., Picard, J. Y., Cate, R. L. & Josso, N. Mutations of the AMH type II receptor in two extended families with persistent Müllerian duct syndrome: lack of phenotype/genotype correlation. Horm. Res. Paediatr. 77, 291–297 (2012).
Vander Borght, M. & Wyns, C. Fertility and infertility: definition and epidemiology. Clin. Biochem. 62, 2–10 (2018).
Gnoth, C. et al. Definition and prevalence of subfertility and infertility. Hum. Reprod. 20, 1144–1147 (2005).
Farikullah, J., Ehtisham, S., Nappo, S., Patel, L. & Hennayake, S. Persistent Müllerian duct syndrome: lessons learned from managing a series of eight patients over a 10-year period and review of literature regarding malignant risk from the Müllerian remnants. BJU Int. 110, E1084–E1089 (2012).
Imbeaud, S. et al. A 27 base-pair deletion of the anti-Müllerian type II receptor gene is the most common cause of the persistent Müllerian duct syndrome. Hum. Mol. Genet. 5, 1269–1277 (1996).
Steven, M., O’Toole, S., Lam, J. P., MacKinlay, G. A. & Cascio, S. Laparoscopy versus ultrasonography for the evaluation of Mullerian structures in children with complex disorders of sex development. Pediatr. Surg. Int. 28, 1161–1164 (2012).
Chua, I. & Samnakay, N. Persistent Müllerian duct syndrome: understanding the challenges. Case Rep. Urol. 2022, 2643833 (2022).
Prakash, N., Khurana, A. & Narula, B. Persistent Müllerian duct syndrome. Indian. J. Pathol. Microbiol. 52, 546–548 (2009).
Mansour, M., Fattal, A., Ouerdane, Y., Alsuliman, T. & Kanjawi, O. A 35-year-old father with persistent Mullerian duct syndrome and seminoma of the right undescended testis: a rare case report. Surg. Case Rep. 7, 271 (2021).
Kolon, T. F., Patel, R. P. & Huff, D. S. Cryptorchidism: diagnosis, treatment, and long-term prognosis. Urol. Clin. North Am. 31, 469–480 (2004).
Sheehan, S. J., Tobbia, I. N., Ismail, M. A., Kelly, D. G. & Duff, F. A. Persistent Müllerian duct syndrome. review and report of 3 cases. Br. J. Urol. 57, 548–551 (1985).
Sankapal, P., Gite, V. A., Agrawal, M., Sane, M. & Singal, A. Persistent Mullerian duct syndrome: a rare case of an adult infertile male with bilateral cryptorchidism. J. Reprod. Infertil. 22, 216–219 (2021).
Chung, E. & Brock, G. B. Cryptorchidism and its impact on male fertility: a state of art review of current literature. Can. Urol. Assoc. J. 5, 210–214 (2011).
Wilkerson, M. L., Bartone, F. F., Fox, L. & Hadziselimovic, F. Fertility potential: a comparison of intra-abdominal and intracanalicular testes by age groups in children. Horm. Res. 55, 18–20 (2001).
Pierantoni, R., Cobellis, G., Meccariello, R. & Fasano, S. in International Review of Cytology Vol. 218 (ed. Jeon, K. W.) 69–141 (Academic, 2002).
Cobellis, G. et al. Spermatogenesis and cryptorchidism. Front. Endocrinol. 5, 63 (2014).
Logsdon, N. T., Gallo, C. M., Sampaio, F. J. B. & Favorito, L. A. Epididymal disjunction anomalies in undescended testis — a factor associated with spermatic obstruction. Int. Braz. J. Urol. 48, 336–346 (2022).
Sinisi, A. A. et al. Antisperm antibodies in cryptorchidism before and after surgery. J. Urol. 160, 1834–1837 (1998).
Urry, R. L., Carrell, D. T., Starr, N. T., Snow, B. W. & Middleton, R. G. The incidence of antisperm antibodies in infertility patients with a history of cryptorchidism. J. Urol. 151, 381–383 (1994).
Adamsen, S. & Börjesson, B. Factors affecting the outcome of orchiopexy for undescended testis. Acta Chir. Scand. 154, 529–533 (1988).
Ciongradi, C. I., Sârbu, I., Iliescu Halițchi, C. O., Benchia, D. & Sârbu, K. Fertility of Cryptorchid testis — an unsolved mystery. Genes 12, 1894 (2021).
Lee, P. A. Fertility in cryptorchidism. Does treatment make a difference? Endocrinol. Metab. Clin. North Am. 22, 479–490 (1993).
Abdelmohsen, S. M. et al. A spectrum of epididymis and vas deferens anomalies among children with cryptorchidism: a retrospective multi-center study. Ann. Pediatr. Surg. 17, 55 (2021).
Vanikar, A. V. et al. Persistent mullerian duct syndrome presenting as retractile testis with hypospadias: a rare entity. World J. Clin. Cases 4, 151–154 (2016).
Thorup, J. et al. What is new in cryptorchidism and hypospadias — a critical review on the testicular dysgenesis hypothesis. J. Pediatr. Surg. 45, 2074–2086 (2010).
Abdullayev, T. & Korkmaz, M. Transvers testicular ectopia: a case report and literature review. Int. J. Surg. Case Rep. 65, 361–364 (2019).
Berkmen, F. Persistent Müllerian duct syndrome with or without transverse testicular ectopia and testis tumours. Br. J. Urol. 79, 122–126 (1997).
Cortes, D., Thorup, J. M. & Visfeldt, J. Cryptorchidism: aspects of fertility and neoplasms. A study including data of 1,335 consecutive boys who underwent testicular biopsy simultaneously with surgery for cryptorchidism. Horm. Res. 55, 21–27 (2001).
Rapley, E. A. et al. A genome-wide association study of testicular germ cell tumor. Nat. Genet. 41, 807–810 (2009).
Turnbull, C. & Rahman, N. Genome-wide association studies provide new insights into the genetic basis of testicular germ-cell tumour. Int. J. Androl. 34, e86–e96 (2011).
Skakkebaek, N. E., Rajpert-De Meyts, E. & Main, K. M. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 16, 972–978 (2001).
Ferguson, L. & Agoulnik, A. I. Testicular cancer and cryptorchidism. Front. Endocrinol. 4, 32 (2013).
Szemes, G. C. & Rubin, D. J. Squamous cell carcinoma in a Müllerian duct cyst. J. Urol. 100, 40–43 (1968).
Hodgson, N. B. Long-term survival from Müllerian duct carcinoma. J. Urol. 116, 313–315 (1976).
Novak, R. W., Raines, R. B. & Neyle Sollee, A. Clear cell carcinoma in a Müllerian duct cyst. Am. J. Clin. Pathol. 76, 339–341 (1981).
Youngson, G. G. Squamous metaplasia complicating a Müllerian duct remnant. Br. J. Urol. 65, 211–212 (1990).
Gilbert, R. F., Ibarra, J., Tansey, L. A. & Shanberg, A. M. Adenocarcinoma in a Müllerian duct cyst. J. Urol. 148, 1262–1264 (1992).
Kato, S., Ito, H. & Kobayashi, K. Squamous cell carcinoma in a Müllerian duct cyst: report of a case. Surg. Today 26, 645–648 (1996).
Warmann, S. W. et al. Giant mullerian duct cyst with malignant transformation in 15-year-old boy. Urology 67, 424.e3–424.e6 (2006).
Shinmura, Y., Yokoi, T. & Tsutsui, Y. A case of clear cell adenocarcinoma of the müllerian duct in persistent Müllerian duct syndrome: the first reported case. Am. J. Surg. Pathol. 26, 1231–1234 (2002).
Thiel, D. D. & Erhard, M. J. Uterine adenosarcoma in a boy with persistent Müllerian duct syndrome: first reported case. J. Pediatr. Surg. 40, e29–e31 (2005).
Romero, F. R. et al. Adenocarcinoma of persistent Müllerian duct remnants: case report and differential diagnosis. Urology 66, 194–195 (2005).
Xing, J. P. et al. Papillary cystadenocarcinoma in a Müllerian duct cyst: report of a case with literature review [Chinese]. Zhonghua Nan Ke Xue 12, 218–221 (2006).
Dimasis, N., Koukourikis, P., Klampatsas, A., Xirou, P. & Sountoulides, P. A unique case of aggressive uterine cancer in a 45-year-old man with persistent Müllerian duct syndrome. Arch. Esp. Urol. 72, 435–438 (2019).
Beatty, J. S., Bhalla, V. K., Hatley, R. M., Pipkin, W. L. & Howell, C. G. Neglected cryptorchidism: delayed recognition of persistent Müllerian duct syndrome and subsequent malignant degeneration. Urology 82, 511–514 (2013).
Dekker, H. M., de Jong, I. J., Sanders, J. & Wolf, R. F. E. Persistent Müllerian duct syndrome. RadioGraphics 23, 309–313 (2003).
Keukens, L., Zijp, G. & Mul, D. Persistent Mullerian duct syndrome: a rare cause of unilateral cryptorchidism. BMJ Case Rep. 2012, bcr0220125722 (2012).
Sarica, K., Albayrak, S., Sargin, H., Can, C. & Keskin, T. Persistent müllerian duct syndrome: report of a case with bilateral cryptorchidism. Int. Urol. Nephrol. 27, 431–438 (1995).
Liang, Y. Y., Zheng, F. F., Dai, Y. P., Zheng, K. L. & Zhou, J. X. Persistent Muellerian duct syndrome with transverse testicular ectopia. Asian J. Androl. 8, 745–747 (2006).
Tiryaki, T., Hücümenoğlu, S. & Atayurt, H. Transverse testicular ectopia associated with persistent Müllerian duct syndrome: a case report. Urol. Int. 74, 190–192 (2005).
Adke, S., Khot, C. I. & Thakkar, H. Persistent Müllerian duct syndrome (PMDS) presenting as bilateral cryptorchidism and left-sided inguinal hernia. BMJ Case Rep. 17, e259784 (2024).
Shah, D. S., Shah, U. S. & Kumaresan, N. Persistent Mullerian duct syndrome: rare presentation in an elderly man. BMJ Case Rep. 13, e234890 (2020).
Barki, D. et al. Testicular masquerade’: a case report of testicular malignancy with persistent Müllerian duct syndrome and transverse testicular ectopia. Ann. R. Coll. Surg. Engl. 106, 466–470 (2024).
Yazar, S. et al. A rare form of persistent Mullerian duct syndrome: transverse testicular ectopia with germ cell testis cancer and hernia uteri inguinalis. Andrologia 53, e14229 (2021).
Mohammadi Sichani, M., Heidarpour, M., Dadkhah, A. & Rezvani, M. Persistent mullerian duct syndrome with an irreducible inguinal hernia. Urol. J. 6, 298–300 (2009).
Gujar, N. N. et al. Male form of persistent Mullerian duct syndrome type I (hernia uteri inguinalis) presenting as an obstructed inguinal hernia: a case report. J. Med. Case Rep. 5, 586 (2011).
Imbeaud, S. et al. Molecular genetics of the persistent müllerian duct syndrome: a study of 19 families. Hum. Mol. Genet. 3, 125–131 (1994).
Xu, H. Y., Zhang, H. X., Xiao, Z., Qiao, J. & Li, R. Regulation of anti-Müllerian hormone (AMH) in males and the associations of serum AMH with the disorders of male fertility. Asian J. Androl. 21, 109–114 (2019).
Misra, M. & Lee, M. M. in Pediatric Endocrinology (ed. Moshang, T.) 103–123 (Mosby, 2005).
Hero, M. et al. Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B. Fertil. Steril. 97, 1242–1247 (2012).
Tan, K. A. et al. The role of androgens in Sertoli cell proliferation and functional maturation: studies in mice with total or Sertoli cell-selective ablation of the androgen receptor. Endocrinology 146, 2674–2683 (2005).
Anawalt, B. D. et al. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J. Clin. Endocrinol. Metab. 81, 3341–3345 (1996).
Matuszczak, E., Hermanowicz, A., Komarowska, M. & Debek, W. Serum AMH in physiology and pathology of male gonads. Int. J. Endocrinol. 2013, 128907 (2013).
Sinclair, A. Genetics 101: cytogenetics and FISH. CMAJ 167, 373–374 (2002).
Bolocan, V. O. et al. Imaging aspects in a case of persistent Müllerian duct syndrome (PMDS): a case report and overview. Cureus 16, e65880 (2024).
Alharbi, K. N., Khushaim, A. O., Alrasheed, M., Akhtar, M. & Neimatallah, M. Radiological findings in persistent Müllerian duct syndrome: case report and review of literature. J. Radiol. Case Rep. 11, 7–14 (2017).
Demir, O., Kizer, O., Sen, V. & Esen, A. A. Persistent Mullerian duct syndrome in adult men diagnosed using laparoscopy. Urology 78, 566 (2011).
Piplani, R. A rare presentation of transverse testicular ectopia and role of laparoscopy. Afr. J. Paediatr. Surg. 20, 74–76 (2023).
Hossaini, D., Wahdat, M. M., Aklaqi, A. & Haidary, M. A rare case report of orchiopexy and hysterectomy in an Afghan boy with persistent Müllerian duct syndrome. Int. J. Surg. Case Rep. 115, 109235 (2024).
Wei, C. H., Wang, N. L., Ting, W. H., Du, Y. C. & Fu, Y. W. Excision of Mullerian duct remnant for persistent Mullerian duct syndrome provides favorable short- and mid-term outcomes. J. Pediatr. Urol. 10, 929–933 (2014).
Noureldin, M. E., Tawfeek, A. M. & Shaker, H. S. Case report: laparoscopic approach for orchiopexy in a 26-year-old man with accidentally discovered persistent Müllerian duct syndrome and bilateral undescended testis. J. Endourol. Case Rep. 4, 75–77 (2018).
Pearce, A., Crigger, C., Hajiran, A. & Al-Omar, O. Robot-assisted laparoscopic management of persistent Mullerian duct structures in a male infant: a novel technique. J. Endourol. Case Rep. 6, 35–38 (2020).
Shalaby, M. M. et al. The management of the persistent Müllerian duct syndrome. Arab. J. Urol. 12, 239–244 (2014).
Schneuer, F. J. et al. Association between male genital anomalies and adult male reproductive disorders: a population-based data linkage study spanning more than 40 years. Lancet Child Adolesc. Health 2, 736–743 (2018).
Du, Q. et al. Persistent Müllerian duct syndrome in an assisted reproductive patient: a novel variant impairs the biosynthesis and secretion of anti-Müllerian hormone (AMH). Asian J. Androl. 25, 534–536 (2023).
Loeff, D. S., Imbeaud, S., Reyes, H. M., Meller, J. L. & Rosenthal, I. M. Surgical and genetic aspects of persistent müllerian duct syndrome. J. Pediatr. Surg. 29, 61–65 (1994).
Chung, H. S., Kim, S. O., Yu, H. S., Kim, S. S. & Kwon, D. D. Transverse testicular ectopia associated with persistent Müllerian duct syndrome treated by transseptal orchiopexy: a case report. Medicine 97, e13305 (2018).
Allin, B. S. R., Dumann, E., Fawkner-Corbett, D., Kwok, C. & Skerritt, C. Systematic review and meta-analysis comparing outcomes following orchidopexy for cryptorchidism before or after 1 year of age. BJS Open 2, 1–12 (2018).
Chan, E., Wayne, C. & Nasr, A. Ideal timing of orchiopexy: a systematic review. Pediatr. Surg. Int. 30, 87–97 (2014).
Brandli, D. W. et al. Persistent Mullerian duct syndrome with bilateral abdominal testis: Surgical approach and review of the literature. J. Pediatr. Urol. 1, 423–427 (2005).
Parelkar, S. V. et al. Laparoscopic management of persistent mullerian duct syndrome. J. Pediatr. Surg. 44, e1–e3 (2009).
Fang, J. et al. A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome. Mol. Genet. Genom. Med. 9, e1801 (2021).
Pettersson, A., Richiardi, L., Nordenskjold, A., Kaijser, M. & Akre, O. Age at surgery for undescended testis and risk of testicular cancer. N. Engl. J. Med. 356, 1835–1841 (2007).
Philips, M. R. et al. Testicular malignancy in persistent Mullerian duct syndrome: experience from an apex cancer center with review of literature. Urologic Oncol. 41, 258.e1–258.e6 (2023).
Petersen, P. M. et al. Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis. J. Clin. Oncol. 20, 1537–1543 (2002).
Böhlen, D., Burkhard, F. C., Mills, R., Sonntag, R. W. & Studer, U. E. Fertility and sexual function following orchiectomy and 2 cycles of chemotherapy for stage I high risk nonseminomatous germ cell cancer. J. Urol. 165, 441–444 (2001).
Huyghe, E. et al. Fertility after testicular cancer treatments: results of a large multicenter study. Cancer 100, 732–737 (2004).
Bowen, D. K., Matulewicz, R. S. & Gong, E. M. Preservation of müllerian structures with laparoscopic management of intra-abdominal testes in persistent müllerian duct syndrome. J. Pediatr. Urol. 12, 65–66 (2016).
Silveri, M., Zaccara, A. & Cappa, M. A simplified management of transverse testicular ectopia in patients with persistent Mullerian duct syndrome. Urol. J. 0, 237–239 (2020).
Vandersteen, D. R., Chaumeton, A. K., Ireland, K. & Tank, E. S. Surgical management of persistent müllerian duct syndrome. Urology 49, 941–945 (1997).
Ahmed, S. F. et al. Society for Endocrinology UK Guidance on the initial evaluation of a suspected difference or disorder of sex development (revised 2021). Clin. Endocrinol. 95, 818–840 (2021).
Trsinar, B. & Muravec, U. R. Fertility potential after unilateral and bilateral orchidopexy for cryptorchidism. World J. Urol. 27, 513–519 (2009).
Lo, W. C., Ng, K. L., Tsui, K. C. T., Ng, W. Y. C. & Yuen, Y. P. L. An unusual case of undescended testis: type II persistent Mullerian duct syndrome. Pathology 51, 335–336 (2019).
Jeyakumar, A., Ramachandran, R., Rangasami, R., Jeyakumar, L. & Gadupudi, V. Reviewing recherche presentations of persistent Mullerian duct syndrome: case reports. Egypt. J. Radiol. Nucl. Med. 53, 73 (2022).
Author information
Authors and Affiliations
Contributions
M.G. and S.W. researched data for the article. All authors contributed substantially to discussion of the content and contributed to the writing, review and editing the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Reviews Urology thanks Emilie Johnson and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Related links
BSPED Special Interest Groups: https://www.bsped.org.uk/clinical-resources/special-interest-groups
DSD Families: https://dsdfamilies.org
SDM Registries: https://www.sdmregistries.org
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
George, M., Wong, S., Mathur, R. et al. Persistent Müllerian duct syndrome — a rare but important cause of male factor infertility. Nat Rev Urol (2025). https://doi.org/10.1038/s41585-025-01108-5
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41585-025-01108-5


